Senate Looks at Drug Companies Behind Massive Price Increases

What's Hot


2 Types of Black Marks Might Vanish From Your Credit File SoonBorrow

6 Ways the Obamacare Overhaul Might Impact Your WalletInsurance

7 Dumb and Costly Moves Homebuyers MakeBorrow

This Free Software Brings Old Laptops Back to LifeMore

Obamacare Replacement Plan Gets ‘F’ Rating from Consumer ReportsFamily

Beware These 12 Common Money MistakesCredit & Debt

21 Restaurants Offering Free Food Right NowSaving Money

17 Ways to Have More Fun for Less MoneySave

House Hunters: Beware of These 6 Mortgage MistakesBorrow

30 Household Uses for Baby OilSave

25 Ways to Spend Less on FoodMore

Nearly Half of Heart-Related Deaths Linked to These 10 Foods and IngredientsFamily

5 Surprising Benefits of Exercising Outdoors in WinterFamily

10 Ways to Save When You’re Making Minimum WageSave

Boost Your Credit Score Fast With These 7 MovesCredit & Debt

7 Painless Ways to Pay Off Your Mortgage Years EarlierBorrow

The Most Sinful City in the U.S. Is … (Hint: It’s Not Vegas)Family

The True Cost of Bad CreditCredit & Debt

10 Companies With the Best 401(k) PlansGrow

This Scam Now Tops ID Theft as the No. 2 Consumer ComplaintFamily

6 Stores With Awesome Reward ProgramsFamily

6 Ways to Save More at Lowe’s and The Home DepotSave

6 Healthful Treats for Your DogFamily

New Study Ranks the Best States in the U.S.Family

Thousands of Millionaires Moving to 1 Country — and Leaving AnotherGrow

Strapped for College Costs? How to Get the Most From FAFSABorrow

6 Overlooked Ways to Save at Chick-fil-AFamily

Ask Stacy: What’s the Fastest Way to Pay Off My Mortgage?Borrow

Where to Sell Your Stuff for Top DollarAround The House

8 Ways to Get a Good Price on a Shiny New AutoCars

Ask Stacy: How Do I Start Over?Credit & Debt

Secret Cell Plans: Savings Verizon, AT&T, T-Mobile and Sprint Don’t Want You to Know AboutFamily

30 Awesome Things to Do in RetirementCollege

14 Super Smart Ways to Save on TravelSave

The Rich Prefer Modest Cars — Should You Join Them?Cars

You’ll Soon Pay More to Shop at CostcoSave

10 Ways to Save When Your Teen Starts DrivingFamily

Are these stunning increases price gouging as investigators suggest, or is the investigation making "a mountain out of a molehill," as one pharmaceutical CEO says?

Nearly two months after hiking the price of a life-saving drug by 5,000 percent overnight, Turing Pharmaceuticals is being investigated by the U.S. Senate.

The Senate’s Special Committee on Aging is targeting Turing and three other drugmakers, Valeant Pharmaceuticals, Retrophin Inc. and Rodelis Therapeutics, for dramatic increases in certain prescription drugs.

In a letter to Turing CEO Martin Shkreli, the committee requested a face-to-face meeting with Shkreli, the former hedge fund manager turned drug company head. Shkreli has come under fire for acquiring the rights to Daraprim, a drug commonly used by HIV patients and pregnant women to treat toxoplasmosis, a potentially deadly parasitic infection, then hiking its price overnight from $13.50 per pill to $750 per pill.

The letter asks for the identity of “the Turing employee responsible for setting the price of Daraprim.”

Turing Pharmaceuticals released this statement regarding the investigation:

“[W]e look forward to having an open and honest dialogue about drug pricing. We’re proud of our patient assistance program which limits out-of-pocket costs for nearly all patients to $10 per prescription, with most receiving Daraprim for $1 or less. More than 60 percent of our revenues are going straight into research and development of new and improved therapies for a variety of indications.”

Meanwhile, Shkreli has dismissed the Senate committee investigation has nothing more than a poorly conducted attempt to gain political capital.

“The senators have their facts wrong,” Shkreli told CNBC. “They’re trying to make a tempest out of a teacup, and a mountain out of a molehill.”

Amid a public outcry over the massive Daraprim price hike, Shkreli agreed to make a modest decrease in the price of the drug by the end of the year, CNBC reports. There’s no word yet on just how much the decrease will be.

“I haven’t decided it to be 10 [percent] or 5 or 20 percent or anything yet, but it’ll be modest,” Shkreli said.

Escalating drug prices have been in the spotlight recently. With some drug price costs skyrocketing upward of 400 to 1,200 percent, people are taking notice.

“We need to get to the bottom of why we’re seeing huge spikes in drug prices that seemingly have no relationship to research and development costs,” said Sen. Claire McCaskill of Missouri, the ranking Democrat on the committee spearheading the drug price probe.

McCaskill added that some of the increases appear to be “little more than price gouging.”

The committee has a tentative hearing date of Dec. 9.

Have you noticed any significant price hikes in your prescription drugs? Share your experiences below or on our Facebook page.

Stacy Johnson

It's not the usual blah, blah, blah

I know... every site you visit wants you to subscribe to their newsletter. But our news and advice is actually worth reading! For 25 years, I've been making people richer without making their eyes glaze over. You'll be glad you did. I guarantee it!

💰🗣📰

Read Next: 10 Simple Money Moves to Make Before the New Year

Check Out Our Hottest Deals!

We're always adding new deals and coupons that'll save you big bucks. See the deals to the right and hundreds more in our Deals section.

Click here to explore 2,001 more deals!